Quick Answer
Lipocine Inc. reported Operating Income of -$10.37 million for fiscal year 2025.
Lipocine Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$10.37M | -797.9% |
| 2024 | -$1.16M | +93.6% |
| 2023 | -$17.93M | -48.0% |
| 2022 | -$12.12M | -485.3% |
| 2021 | $3.15M | +117.5% |
| 2020 | -$18.00M | -39.5% |
| 2019 | -$12.90M | -13.9% |
| 2018 | -$11.33M | +46.6% |
| 2017 | -$21.22M | -10.6% |
| 2016 | -$19.19M | -4.4% |
| 2015 | -$18.38M | +10.2% |
| 2014 | -$20.48M | -91.7% |
| 2013 | -$10.68M | -375.5% |
| 2012 | $3.88M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.36M | -27.8% | -39.8% |
| June 30, 2025 | -$2.40M | +27.0% | -15.0% |
| March 31, 2025 | -$2.09M | -164.9% | +20.5% |
| September 30, 2024 | -$2.63M | +62.7% | +20.1% |
| June 30, 2024 | -$3.29M | +16.8% | -202.2% |
| March 31, 2024 | $3.22M | +174.3% | +145.8% |
| September 30, 2023 | -$7.04M | -142.9% | -78.1% |
| June 30, 2023 | -$3.96M | -12.1% | +8.8% |
- Lipocine Inc. showed a decrease of -797.9% in Operating Income compared to the prior fiscal year.
- Over the 2012–2025 period, Lipocine Inc.’s operating income has declined by 367.5% (from $3.88 million to -$10.37 million).
- The most recent figure is from Lipocine Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: